María Ángeles Montalbán

Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation

Bruno Paiva, María‐Belén Vídriales, Jorge Cerveró et al. · Blood · 2008 · 475 citations · Full text

Medicine, Hematology, Immunology +17

Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma

Joaquín Martínez‐López, Juan José Lahuerta, François Pépin et al. · Blood · 2014 · 427 citations · Full text

Medicine, Hematology, Oncology +17

Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patients

Bruno Paiva, María‐Belén Vídriales, José J. Pérez et al. · Haematologica · 2009 · 109 citations · Full text

Medicine, Hematology, Pathology +17

The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients

Bruno Paiva, María‐Belén Vídriales, Gema Mateo et al. · Blood · 2009 · 75 citations · Full text

Medicine, Hematology, Pathology +15

Evaluation of minimal residual disease in multiple myeloma patients by fluorescent‐polymerase chain reaction: the prognostic impact of achieving molecular response

Pilar Martínez‐Sánchez, Laura Montejano, María Eugenia Sarasquete et al. · British Journal of Haematology · 2008 · 58 citations

Medicine, Hematology, Oncology +17